Eterna Therapeutics Ownership 2024 | Who Owns Eterna Therapeutics Now?

Overview RevenueFinancials Chart

Institutional Ownership

10.43%

Insider Ownership

39.31%

Retail Ownership

50.26%

Institutional Holders

18.00

Eterna Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CYPRESS POINT WEALTH MANAGEMENT, LLC	3.09%	0.45%	94,375	-	-	320,875,000	Mar 31, 2023
NAVITER WEALTH, LLC	2.61%	0.09%	79,666	45	0.06%	270,864,000	Mar 31, 2023
CI PRIVATE WEALTH, LLC	2.01%	0.00%	61,189	-	-	214,071,000	Mar 31, 2023
BLACKROCK INC.	0.77%	-	23,363	222	0.96%	79,434,000	Mar 31, 2023
VANGUARD GROUP INC	0.63%	-	19,068	-10,000	-34.40%	64,831,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.46%	-	13,985	-	-	48,947,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	0.43%	0.00%	13,053	-4,483	-25.56%	44,000	Mar 31, 2023
BALDWIN BROTHERS LLC/MA	0.31%	0.00%	9,470	278	3.02%	32,198,000	Mar 31, 2023
UBS GROUP AG	0.13%	-	3,864	3,864	100.00%	13,138,000	Mar 31, 2023
CARMICHAEL HILL & ASSOCIATES, INC.	0.00%	0.00%	75	-	-	255,000	Mar 31, 2023
MONTAG A & ASSOCIATES INC	0.00%	-	70	-	-	238,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	50	-1,313	-96.33%	170,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.00%	-	19	-	-	67,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	16	-10	-38.46%	54,000	Mar 31, 2023
CITIGROUP INC	0.00%	-	15	-	-	53,000	Mar 31, 2023
ASPIRE PRIVATE CAPITAL, LLC	0.00%	-	10	-	-	34,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.00%	-	9	-	-	31,000	Mar 31, 2023
FMR LLC	-	-	1	-	-	4,000	Mar 31, 2023
CREDIT SUISSE AG/	-	-	-	-120	-100.00%	-	Mar 31, 2023

Eterna Therapeutics's largest institutional shareholder is CYPRESS POINT WEALTH MANAGEMENT, LLC, holding 3.09% of the company's total share outstanding, currently valued at $320.88M. The top 10 institutional shareholders own together 10.43% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CYPRESS POINT WEALTH MANAGEMENT, LLC	3.09%	0.45%	94,375	-	-	320,875,000	Mar 31, 2023
NAVITER WEALTH, LLC	2.61%	0.09%	79,666	45	0.06%	270,864,000	Mar 31, 2023
BALDWIN BROTHERS LLC/MA	0.31%	0.00%	9,470	278	3.02%	32,198,000	Mar 31, 2023
CI PRIVATE WEALTH, LLC	2.01%	0.00%	61,189	-	-	214,071,000	Mar 31, 2023
CARMICHAEL HILL & ASSOCIATES, INC.	0.00%	0.00%	75	-	-	255,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	0.43%	0.00%	13,053	-4,483	-25.56%	44,000	Mar 31, 2023
MONTAG A & ASSOCIATES INC	0.00%	-	70	-	-	238,000	Mar 31, 2023
ASPIRE PRIVATE CAPITAL, LLC	0.00%	-	10	-	-	34,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.46%	-	13,985	-	-	48,947,000	Mar 31, 2023
UBS GROUP AG	0.13%	-	3,864	3,864	100.00%	13,138,000	Mar 31, 2023
BLACKROCK INC.	0.77%	-	23,363	222	0.96%	79,434,000	Mar 31, 2023
VANGUARD GROUP INC	0.63%	-	19,068	-10,000	-34.40%	64,831,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.00%	-	19	-	-	67,000	Mar 31, 2023
CITIGROUP INC	0.00%	-	15	-	-	53,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	50	-1,313	-96.33%	170,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	16	-10	-38.46%	54,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.00%	-	9	-	-	31,000	Mar 31, 2023
FMR LLC	-	-	1	-	-	4,000	Mar 31, 2023
CREDIT SUISSE AG/	-	-	-	-120	-100.00%	-	Mar 31, 2023

The largest Eterna Therapeutics shareholder by % of total assets is CYPRESS POINT WEALTH MANAGEMENT, LLC. The company owns 94.38K shares of Eterna Therapeutics (ERNA), representing 0.45% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
UBS GROUP AG	0.13%	-	3,864	3,864	100.00%	13,138,000	Mar 31, 2023
BALDWIN BROTHERS LLC/MA	0.31%	0.00%	9,470	278	3.02%	32,198,000	Mar 31, 2023
BLACKROCK INC.	0.77%	-	23,363	222	0.96%	79,434,000	Mar 31, 2023
NAVITER WEALTH, LLC	2.61%	0.09%	79,666	45	0.06%	270,864,000	Mar 31, 2023
FMR LLC	-	-	1	-	-	4,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.00%	-	9	-	-	31,000	Mar 31, 2023
CITIGROUP INC	0.00%	-	15	-	-	53,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.00%	-	19	-	-	67,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.46%	-	13,985	-	-	48,947,000	Mar 31, 2023
ASPIRE PRIVATE CAPITAL, LLC	0.00%	-	10	-	-	34,000	Mar 31, 2023
MONTAG A & ASSOCIATES INC	0.00%	-	70	-	-	238,000	Mar 31, 2023
CARMICHAEL HILL & ASSOCIATES, INC.	0.00%	0.00%	75	-	-	255,000	Mar 31, 2023
CI PRIVATE WEALTH, LLC	2.01%	0.00%	61,189	-	-	214,071,000	Mar 31, 2023
CYPRESS POINT WEALTH MANAGEMENT, LLC	3.09%	0.45%	94,375	-	-	320,875,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	16	-10	-38.46%	54,000	Mar 31, 2023
CREDIT SUISSE AG/	-	-	-	-120	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	0.00%	-	50	-1,313	-96.33%	170,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	0.43%	0.00%	13,053	-4,483	-25.56%	44,000	Mar 31, 2023
VANGUARD GROUP INC	0.63%	-	19,068	-10,000	-34.40%	64,831,000	Mar 31, 2023

As of Mar 31 2023, Eterna Therapeutics's largest institutional buyer is UBS GROUP AG. The company purchased 3.86K stocks of ERNA, valued at $13.14M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	0.63%	-	19,068	-10,000	-34.40%	64,831,000	Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC	0.43%	0.00%	13,053	-4,483	-25.56%	44,000	Mar 31, 2023
MORGAN STANLEY	0.00%	-	50	-1,313	-96.33%	170,000	Mar 31, 2023
CREDIT SUISSE AG/	-	-	-	-120	-100.00%	-	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	16	-10	-38.46%	54,000	Mar 31, 2023
CYPRESS POINT WEALTH MANAGEMENT, LLC	3.09%	0.45%	94,375	-	-	320,875,000	Mar 31, 2023
CI PRIVATE WEALTH, LLC	2.01%	0.00%	61,189	-	-	214,071,000	Mar 31, 2023
CARMICHAEL HILL & ASSOCIATES, INC.	0.00%	0.00%	75	-	-	255,000	Mar 31, 2023
MONTAG A & ASSOCIATES INC	0.00%	-	70	-	-	238,000	Mar 31, 2023
ASPIRE PRIVATE CAPITAL, LLC	0.00%	-	10	-	-	34,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	0.46%	-	13,985	-	-	48,947,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.00%	-	19	-	-	67,000	Mar 31, 2023
CITIGROUP INC	0.00%	-	15	-	-	53,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.00%	-	9	-	-	31,000	Mar 31, 2023
FMR LLC	-	-	1	-	-	4,000	Mar 31, 2023
NAVITER WEALTH, LLC	2.61%	0.09%	79,666	45	0.06%	270,864,000	Mar 31, 2023
BLACKROCK INC.	0.77%	-	23,363	222	0.96%	79,434,000	Mar 31, 2023
BALDWIN BROTHERS LLC/MA	0.31%	0.00%	9,470	278	3.02%	32,198,000	Mar 31, 2023
UBS GROUP AG	0.13%	-	3,864	3,864	100.00%	13,138,000	Mar 31, 2023

As of Mar 31 2023, Eterna Therapeutics's biggest institutional seller is VANGUARD GROUP INC. The company sold -10.00K shares of ERNA, valued at $64.83M.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
UBS GROUP AG	0.13%	-	3,864	3,864	100.00%	13,138,000	Mar 31, 2023

Eterna Therapeutics's largest new institutional shareholder by number of shares is UBS GROUP AG, purchased 3.86K shares, valued at $13.14M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CREDIT SUISSE AG/	-	-	-	-120	-100.00%	-	Mar 31, 2023

Eterna Therapeutics's largest sold out institutional shareholder by shares sold is CREDIT SUISSE AG/, sold -0.12K shares, valued at -, as of undefined.

Eterna Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD INDEX FUNDS	0.00%	52,198	27,300	109.65%	Dec 31, 2023
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	5,904	-	-	Jan 31, 2024
PROSHARES TRUST	0.00%	247	-	-	Feb 29, 2024
EQ ADVISORS TRUST	0.00%	476	-	-	Dec 31, 2023

Eterna Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 52.20K shares, compromising 0.00% of its total assets.

Eterna Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 23	18	-
31 Dec, 22	18	-

As of 31 Mar 23, 18 institutions are holding Eterna Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 23	318,298	-3.49%
31 Dec, 22	329,815	-

Eterna Therapeutics (ERNA) has 318.30K shares outstanding as of 31 Mar 23, down -3.49% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 23	10.43%	-6.97%
31 Dec, 22	11.21%	-

As of 31 Mar 23, Eterna Therapeutics is held by 10.43% institutional shareholders, representing a -6.97% negative growth compared to 31 Dec 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 23	3	-
31 Dec, 22	-	-

3 institutional shareholders have increased their position in ERNA stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 23	4	-
31 Dec, 22	-	-

4 institutional shareholders have reduced their position in ERNA stock as of 31 Mar 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 23	18	-	318,298	-3.49%	10.43%	-6.97%	3	-	4	-
31 Dec, 22	18	-	329,815	-	11.21%	-	-	-	-	-

Eterna Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 20, 2023	Cherington Charles	10 percent owner	-	P-Purchase	Buy	3,125,976	$1.43	$4.47M	3,125,976
Dec 20, 2023	Cherington Charles	10 percent owner	-	P-Purchase	Buy	2,307,692	$1.43	$3.30M	2,307,692
Dec 20, 2023	Cherington Charles	10 percent owner	-	P-Purchase	Buy	523,512	$1.43	$748.62K	523,512
Dec 20, 2023	Cherington Charles	10 percent owner	-	P-Purchase	Buy	-	$1.92	-	-
Dec 18, 2023	Freebird Partners LP	10 percent owner	-	P-Purchase	Buy	1,041,992	$1.43	$1.49M	1,991,394
Dec 18, 2023	Freebird Partners LP	10 percent owner	-	P-Purchase	Buy	520,996	$1.92	$1000.00K	783,233

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Dec 20, 2023	Cherington Charles	10 percent owner	-	P-Purchase	Buy	3,125,976	$1.43	$4.47M	3,125,976
Dec 20, 2023	Cherington Charles	10 percent owner	-	P-Purchase	Buy	2,307,692	$1.43	$3.30M	2,307,692
Dec 20, 2023	Cherington Charles	10 percent owner	-	P-Purchase	Buy	523,512	$1.43	$748.62K	523,512
Dec 20, 2023	Cherington Charles	10 percent owner	-	P-Purchase	Buy	-	$1.92	-	-
Dec 18, 2023	Freebird Partners LP	10 percent owner	-	P-Purchase	Buy	1,041,992	$1.43	$1.49M	1,991,394
Dec 18, 2023	Freebird Partners LP	10 percent owner	-	P-Purchase	Buy	520,996	$1.92	$1000.00K	783,233

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Dec 20, 2023	Cherington Charles	10 percent owner	-	H-ExpireLong	Sell	2,307,692	$2.61	$6.02M	-
Dec 20, 2023	Cherington Charles	10 percent owner	-	H-ExpireLong	Sell	523,512	$3.28	$1.72M	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Apr 29, 2024	Cicala Peter	director	-	A-Award	Buy	88,946	$1.74	$154.77K	88,946
Apr 29, 2024	Gurrola Sandra M	officer	Sr. VP of Finance	A-Award	Buy	80,000	$1.74	$139.20K	80,000
Apr 29, 2024	Bristol James Arthur	director	-	A-Award	Buy	124,525	$1.74	$216.67K	124,525
Feb 16, 2024	Cicala Peter		-		Buy	-	-	-	-
Jan 03, 2024	Luther Sanjeev	director, officer	President and CEO	A-Award	Buy	1,685,218	$1.80	$3.03M	1,685,218
Jan 03, 2024	Clarke Dorothy J	director, officer	General Counsel	A-Award	Buy	168,521	$1.80	$303.34K	168,521
Jan 03, 2024	Luther Sanjeev		-		Buy	-	-	-	-
Dec 20, 2023	Cherington Charles	10 percent owner	-	P-Purchase	Buy	3,125,976	$1.43	$4.47M	3,125,976
Dec 20, 2023	Cherington Charles	10 percent owner	-	P-Purchase	Buy	2,307,692	$1.43	$3.30M	2,307,692
Dec 20, 2023	Cherington Charles	10 percent owner	-	P-Purchase	Buy	523,512	$1.43	$748.62K	523,512
Dec 20, 2023	Cherington Charles	10 percent owner	-	P-Purchase	Buy	-	$1.92	-	-
Dec 20, 2023	Cherington Charles	10 percent owner	-	H-ExpireLong	Sell	2,307,692	$2.61	$6.02M	-
Dec 20, 2023	Cherington Charles	10 percent owner	-	H-ExpireLong	Sell	523,512	$3.28	$1.72M	-
Dec 18, 2023	Freebird Partners LP	10 percent owner	-	P-Purchase	Buy	1,041,992	$1.43	$1.49M	1,991,394
Dec 18, 2023	Freebird Partners LP	10 percent owner	-	A-Award	Buy	524,474	$1.43	$750.00K	949,402
Dec 18, 2023	Freebird Partners LP	10 percent owner	-	P-Purchase	Buy	520,996	$1.92	$1000.00K	783,233
Dec 18, 2023	Freebird Partners LP	10 percent owner	-	D-Return	Buy	424,928	$3.28	$1.39M	524,474
Dec 18, 2023	Freebird Partners LP	10 percent owner	-	D-Return	Buy	524,474	$2.61	$1.37M	424,928
Nov 13, 2023	Bristol James Arthur		-		Buy	-	-	-	-
Sep 01, 2023	Clarke Dorothy J		-		Buy	-	-	-	-

The last insider sell of Eterna Therapeutics's stock was made by Cherington Charles on Dec 20 2023, selling 2,307,692 shares at $2.61 per share (valued at $6.02M). The last insider buy of ERNA was made by Cherington Charles on Dec 20 2023, buying 3,125,976 shares at $1.43 per share (worth $4.47M).

Eterna Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	2	-	-
Q4 2023	9	2	450.00%
Q3 2023	8	-	-
Q2 2023	1	4	25.00%
Q1 2023	1	-	-
Q4 2022	-	1	-
Q3 2022	1	1	100.00%

2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Eterna Therapeutics's insiders, as of Q1 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	-	-	-
Q4 2023	6	-	-
Q3 2023	8	-	-
Q2 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	-	-	-
Q3 2022	-	-	-

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Eterna Therapeutics's stocks.

Eterna Therapeutics Peer Ownership

Ticker	Company
ZURA	Zura Bio Limited
ZVSA	ZyVersa Therapeutics, Inc.
ABOS	Acumen Pharmaceuticals, Inc.
TCRX	TScan Therapeutics, Inc.
RLAY	Relay Therapeutics, Inc.
RNAZ	TransCode Therapeutics, Inc.
PALI	Palisade Bio, Inc.
VECT	VectivBio Holding AG
XFOR	X4 Pharmaceuticals, Inc.
RCUS	Arcus Biosciences, Inc.
UNCY	Unicycive Therapeutics, Inc.
ITOS	iTeos Therapeutics, Inc.
INZY	Inozyme Pharma, Inc.
IMMX	Immix Biopharma, Inc.
DAWN	Day One Biopharmaceuticals, Inc.
ANNX	Annexon, Inc.
GPCR	Structure Therapeutics Inc.
CGEM	Cullinan Oncology, Inc.
REVB	Revelation Biosciences, Inc.
PHIO	Phio Pharmaceuticals Corp.
APLS	Apellis Pharmaceuticals, Inc.

ERNA Ownership FAQ

Who Owns Eterna Therapeutics?

Eterna Therapeutics is owned by institutional shareholders (10.43%), insiders (39.31%), and public (50.26%). The largest institutional shareholder of Eterna Therapeutics is CYPRESS POINT WEALTH MANAGEMENT, LLC (3.09% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Who are the major institutional shareholders of Eterna Therapeutics?

Eterna Therapeutics's major institutional shareholders are CYPRESS POINT WEALTH MANAGEMENT, LLC, NAVITER WEALTH, LLC, CI PRIVATE WEALTH, LLC, BLACKROCK INC., and VANGUARD GROUP INC. The top five shareholders own together 9.10% of the company's share outstanding.

How many Eterna Therapeutics shareholders are there?

As of Mar 2023, there are 18 institutional shareholders of Eterna Therapeutics.

What percentage of Eterna Therapeutics is owned by CYPRESS POINT WEALTH MANAGEMENT, LLC?

CYPRESS POINT WEALTH MANAGEMENT, LLC owns 94.38K shares of Eterna Therapeutics, representing 3.09% of the company's total shares outstanding, valued at $320.88M (as of Mar 2023).

What percentage of Eterna Therapeutics is owned by NAVITER WEALTH, LLC?

As of Mar 2023, NAVITER WEALTH, LLC holds 79.67K shares of Eterna Therapeutics (ERNA), compromising 2.61% of the company, valued at $270.86M.

What percentage of Eterna Therapeutics is owned by CI PRIVATE WEALTH, LLC?

CI PRIVATE WEALTH, LLC is the third largest holder of Eterna Therapeutics. The company owns 61.19K of the company's shares outstanding (worth $214.07M).